Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime

Author(s):

Experts discuss the evidence supporting the continuous relationship between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD), as recognized by the National Lipid Association, and explore how Lp(a) levels may change throughout a person’s lifetime or in response to lifestyle factors.

EP: 1.Lp(a) in ASCVD and Guideline Recommendations

EP: 2.Introduction and Burden of Atherosclerotic Disease and Aortic Stenosis

EP: 3.The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis

EP: 4.Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease

Now Viewing

EP: 5.Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime

Video content above is prompted by the following:

Historically, Lp(a) levels of at least 125 nmol/L (or 50 mg/dL) have been considered elevated. However, the National Lipid Association—or NLA—now recognizes the relationship between Lp(a) and ASCVD to be continuous. Could you speak to the evidence supporting this conclusion?
How, if at all, do Lp(a) levels change throughout a person’s lifetime or in response to lifestyle factors?